107 related articles for article (PubMed ID: 27046044)
1. Re: The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Safer U; Binay Safer V
Clin Nutr; 2016 Jun; 35(3):764. PubMed ID: 27046044
[No Abstract] [Full Text] [Related]
2. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
3. Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Jun; 35(3):765-6. PubMed ID: 27026511
[No Abstract] [Full Text] [Related]
4. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma.
Freeny PC
Ann Oncol; 1999; 10 Suppl 4():12-7. PubMed ID: 10436776
[TBL] [Abstract][Full Text] [Related]
5. Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Fujimoto Y; Iida T; Yagi S; Taura K; Hatano E; Okajima H; Uemoto S
Ann Surg Oncol; 2017 Apr; 24(4):1037-1045. PubMed ID: 27837297
[TBL] [Abstract][Full Text] [Related]
6. Multi-detector spiral CT diagnosis of common bile duct ampullary carcinoma.
Zhao DZ; Guo Y; Sun YP; Liu HM; Zhang Z; Ma QL; Wang YS; Chen CL
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3549-3553. PubMed ID: 28925490
[TBL] [Abstract][Full Text] [Related]
7. Rapidly aggravated skeletal muscle metastases from an intrahepatic cholangiocarcinoma.
Lee J; Lee SW; Han SY; Baek YH; Kim SY; Rhyou HI
World J Gastroenterol; 2015 Feb; 21(6):1989-93. PubMed ID: 25684968
[TBL] [Abstract][Full Text] [Related]
8. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
9. CT features of intraductal intrahepatic cholangiocarcinoma.
Lee JW; Han JK; Kim TK; Kim YH; Choi BI; Han MC; Suh KS; Kim SW
AJR Am J Roentgenol; 2000 Sep; 175(3):721-5. PubMed ID: 10954456
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings.
Han JK; Choi BI; Kim AY; An SK; Lee JW; Kim TK; Kim SW
Radiographics; 2002; 22(1):173-87. PubMed ID: 11796906
[TBL] [Abstract][Full Text] [Related]
12. Small pancreatic carcinoma misdiagnosed as superficially spreading cholangiocarcinoma.
Igami T; Yokoyama Y; Nishio H; Ebata T; Shimoyama Y; Nakamura S; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(4):579-84. PubMed ID: 19259611
[TBL] [Abstract][Full Text] [Related]
13. [A case report of cholangiectasis with cholangiocarcinoma].
Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
[TBL] [Abstract][Full Text] [Related]
14. [Imaging Analysis in Cases with Clonorchiasis-Associated Cholangiocarcinoma].
Xu SC; Wen ZB
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Jun; 34(3):239-44. PubMed ID: 30129725
[TBL] [Abstract][Full Text] [Related]
15. Imaging of intrahepatic and hilar cholangiocarcinoma.
Choi BI; Lee JM; Han JK
Abdom Imaging; 2004; 29(5):548-57. PubMed ID: 15185025
[No Abstract] [Full Text] [Related]
16. Pathology of cholangiocarcinoma.
Lim JH; Park CK
Abdom Imaging; 2004; 29(5):540-7. PubMed ID: 15383897
[No Abstract] [Full Text] [Related]
17. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
18. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cholangiocarcinoma arising in Caroli's disease.
Jang MH; Lee YJ; Kim H
Clin Mol Hepatol; 2014 Dec; 20(4):402-5. PubMed ID: 25548748
[No Abstract] [Full Text] [Related]
20. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
Stretch C; Aubin JM; Mickiewicz B; Leugner D; Al-Manasra T; Tobola E; Salazar S; Sutherland FR; Ball CG; Dixon E; Vogel HJ; Damaraju S; Baracos VE; Bathe OF
PLoS One; 2018; 13(5):e0196235. PubMed ID: 29723245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
